CONCLUSION
In conclusion, oral activated charcoal showed promise in reducing uremic toxins in Iraqi patients on maintenance hemodialysis. However, larger, longer-term studies with multiple centers and a greater number of patients are needed to confirm its nephroprotective effect. Further research is also needed to determine its potential benefits in pre-dialyzed patients.